Alnylam Pharmaceuticals | ALNY - Ingresos Por Ventas





Ventas Cambio Fecha
Acadia Pharmaceuticals USD 307.96M 39.9M 2026-06
Agios Pharmaceuticals USD 44.74M 25.94M 2026-06
Alnylam Pharmaceuticals USD 1.29B 120M 2026-06
Amgen USD 10.1B 1.48B 2026-06
Arrowhead Research USD 75.23M 1.49M 2026-06
BioCryst Pharmaceuticals USD 218.25M 188.3M 2026-06
BioMarin Pharmaceutical USD 990M 224M 2026-06
Incyte USD 1.67B 400M 2026-06
Ionis Pharmaceuticals USD 268M 22M 2026-06
Moderna USD 100M 289M 2026-06
Neurocrine Biosciences USD 959M 148M 2026-06
Novartis USD 13.11B 750M 2026-03
PTC Therapeutics USD 361M 88M 2026-06
Regeneron Pharmaceuticals USD 4.29B 690M 2026-06
Sangamo BioSciences USD 356K 125K 2024-06
Sanofi EUR 12.14B 65M 2026-03
Sarepta Therapeutics USD 401.3M 329.5M 2026-06
Takeda JPY 1.22T 130B 2026-06
Tectonic Therapeutic USD 0 0 2024-12
Ultragenyx Pharmaceutical USD 214M 78M 2026-06
Vertex Pharmaceuticals USD 3.33B 340M 2026-06
Xencor USD 51.22M 46.71M 2026-06